EMEA-000402-PIP03-17-M06
Key facts
| Invented name |
Vimpat
|
| Active substance |
lacosamide
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0247/2022
|
| PIP number |
EMEA-000402-PIP03-17-M06
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of generalised epilepsy and epileptic syndromes
|
| Route(s) of administration |
|
| Contact for public enquiries |
UCB Pharma S.A.
E-mail: UCBCares.IE@ucb.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|